These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30045665)

  • 1. Lack of Benefit on Brain Edema, Blood-Brain Barrier Permeability, or Cognitive Outcome in Global Inducible High Mobility Group Box 1 Knockout Mice Despite Tissue Sparing after Experimental Traumatic Brain Injury.
    Aneja RK; Alcamo AM; Cummings J; Vagni V; Feldman K; Wang Q; Dixon CE; Billiar TR; Kochanek PM
    J Neurotrauma; 2019 Jan; 36(2):360-369. PubMed ID: 30045665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGB1 a-Box Reverses Brain Edema and Deterioration of Neurological Function in a Traumatic Brain Injury Mouse Model.
    Yang L; Wang F; Yang L; Yuan Y; Chen Y; Zhang G; Fan Z
    Cell Physiol Biochem; 2018; 46(6):2532-2542. PubMed ID: 29742510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of high mobility group box-1 protein on cerebral edema, blood-brain barrier, oxidative stress and apoptosis in an experimental traumatic brain injury model.
    Evran S; Calis F; Akkaya E; Baran O; Cevik S; Katar S; Gurevin EG; Hanimoglu H; Hatiboglu MA; Armutak EI; Karatas E; Kocyigit A; Kaynar MY
    Brain Res Bull; 2020 Jan; 154():68-80. PubMed ID: 31715313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury.
    Tan SW; Zhao Y; Li P; Ning YL; Huang ZZ; Yang N; Liu D; Zhou YG
    J Neuroinflammation; 2021 Oct; 18(1):241. PubMed ID: 34666797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: Chronic neuroinflammatory, behavioral, and epileptogenic consequences.
    Webster KM; Shultz SR; Ozturk E; Dill LK; Sun M; Casillas-Espinosa P; Jones NC; Crack PJ; O'Brien TJ; Semple BD
    Exp Neurol; 2019 Oct; 320():112979. PubMed ID: 31229637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction.
    Okuma Y; Liu K; Wake H; Liu R; Nishimura Y; Hui Z; Teshigawara K; Haruma J; Yamamoto Y; Yamamoto H; Date I; Takahashi HK; Mori S; Nishibori M
    Neuropharmacology; 2014 Oct; 85():18-26. PubMed ID: 24859607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenesis after traumatic brain injury - The complex role of HMGB1 and neuroinflammation.
    Manivannan S; Marei O; Elalfy O; Zaben M
    Neuropharmacology; 2021 Feb; 183():108400. PubMed ID: 33189765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-high mobility group box-1 antibody therapy for traumatic brain injury.
    Okuma Y; Liu K; Wake H; Zhang J; Maruo T; Date I; Yoshino T; Ohtsuka A; Otani N; Tomura S; Shima K; Yamamoto Y; Yamamoto H; Takahashi HK; Mori S; Nishibori M
    Ann Neurol; 2012 Sep; 72(3):373-84. PubMed ID: 22915134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injury.
    Chen X; Chen C; Fan S; Wu S; Yang F; Fang Z; Fu H; Li Y
    J Neuroinflammation; 2018 Apr; 15(1):116. PubMed ID: 29678169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-High Mobility Group Box 1 Antibody Therapy May Prevent Cognitive Dysfunction After Traumatic Brain Injury.
    Okuma Y; Wake H; Teshigawara K; Takahashi Y; Hishikawa T; Yasuhara T; Mori S; Takahashi HK; Date I; Nishibori M
    World Neurosurg; 2019 Feb; 122():e864-e871. PubMed ID: 30391757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.
    Chen X; Wu S; Chen C; Xie B; Fang Z; Hu W; Chen J; Fu H; He H
    J Neuroinflammation; 2017 Jul; 14(1):143. PubMed ID: 28738820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of Da Chuanxiong Formula against cognitive and motor deficits in a rat controlled cortical impact model of traumatic brain injury.
    Liu ZK; Ng CF; Shiu HT; Wong HL; Chin WC; Zhang JF; Lam PK; Poon WS; Lau CB; Leung PC; Ko CH
    J Ethnopharmacol; 2018 May; 217():11-22. PubMed ID: 29425850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of elevated 20‑HETE in the breakdown of blood brain barrier and the severity of brain edema in experimental traumatic brain injury.
    Lu L; Wang M; Yuan F; Wei X; Li W
    Mol Med Rep; 2018 May; 17(5):7339-7345. PubMed ID: 29568904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sesamin alleviates blood-brain barrier disruption in mice with experimental traumatic brain injury.
    Liu YL; Xu ZM; Yang GY; Yang DX; Ding J; Chen H; Yuan F; Tian HL
    Acta Pharmacol Sin; 2017 Nov; 38(11):1445-1455. PubMed ID: 28770828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traumatic Brain Injury and Blood-Brain Barrier (BBB): Underlying Pathophysiological Mechanisms and the Influence of Cigarette Smoking as a Premorbid Condition.
    Sivandzade F; Alqahtani F; Cucullo L
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoE Influences the Blood-Brain Barrier Through the NF-κB/MMP-9 Pathway After Traumatic Brain Injury.
    Teng Z; Guo Z; Zhong J; Cheng C; Huang Z; Wu Y; Tang S; Luo C; Peng X; Wu H; Sun X; Jiang L
    Sci Rep; 2017 Jul; 7(1):6649. PubMed ID: 28751738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rhFGF20 promotes angiogenesis and vascular repair following traumatic brain injury by regulating Wnt/β-catenin pathway.
    Guo R; Wang X; Fang Y; Chen X; Chen K; Huang W; Chen J; Hu J; Liang F; Du J; Dordoe C; Tian X; Lin L
    Biomed Pharmacother; 2021 Nov; 143():112200. PubMed ID: 34649342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-23b improves cognitive impairments in traumatic brain injury by targeting ATG12-mediated neuronal autophagy.
    Sun L; Liu A; Zhang J; Ji W; Li Y; Yang X; Wu Z; Guo J
    Behav Brain Res; 2018 Mar; 340():126-136. PubMed ID: 27630106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irisin Rescues Blood-Brain Barrier Permeability following Traumatic Brain Injury and Contributes to the Neuroprotection of Exercise in Traumatic Brain Injury.
    Guo P; Jin Z; Wang J; Sang A; Wu H
    Oxid Med Cell Longev; 2021; 2021():1118981. PubMed ID: 34697562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathological role of NLRs and AIM2 inflammasome-mediated pyroptosis in damaged blood-brain barrier after traumatic brain injury.
    Ge X; Li W; Huang S; Yin Z; Xu X; Chen F; Kong X; Wang H; Zhang J; Lei P
    Brain Res; 2018 Oct; 1697():10-20. PubMed ID: 29886252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.